Ditemukan 610 dokumen dengan kata kunci 7597 |
Simpan CSV  |
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer
|
|
Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients
|
|
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA
|
|
Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy
|
|
A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer
|
|
Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer
|
|
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy
|
|
Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy
|
|
Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer?†
|
|
Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer
|
|